Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 7
1947 8
1948 2
1949 1
1950 1
1951 4
1953 2
1954 4
1956 2
1957 3
1959 2
1960 3
1962 4
1963 1
1964 1
1967 1
1968 1
1969 2
1971 1
1972 4
1973 4
1974 2
1975 5
1976 2
1977 2
1978 2
1979 1
1980 3
1984 1
1985 1
1988 1
1991 1
1992 2
1993 1
1995 1
2003 1
2004 2
2005 2
2006 1
2007 2
2008 4
2009 7
2010 5
2011 5
2012 2
2013 5
2014 3
2015 5
2016 6
2017 5
2018 2
2019 8
2020 6
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

155 results
Results by year
Filters applied: . Clear all
Page 1
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.
Dickson MA, Schwartz GK, Keohan ML, D'Angelo SP, Gounder MM, Chi P, Antonescu CR, Landa J, Qin LX, Crago AM, Singer S, Koff A, Tap WD. Dickson MA, et al. Among authors: landa j. JAMA Oncol. 2016 Jul 1;2(7):937-40. doi: 10.1001/jamaoncol.2016.0264. JAMA Oncol. 2016. PMID: 27124835 Free PMC article. Clinical Trial.
Clinical significance of Kelch-like protein 11 antibodies.
Maudes E, Landa J, Muñoz-Lopetegi A, Armangue T, Alba M, Saiz A, Graus F, Dalmau J, Sabater L. Maudes E, et al. Among authors: landa j. Neurol Neuroimmunol Neuroinflamm. 2020 Jan 17;7(3):e666. doi: 10.1212/NXI.0000000000000666. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 31953318 Free PMC article.
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy.
Smith EL, Mailankody S, Staehr M, Wang X, Senechal B, Purdon TJ, Daniyan AF, Geyer MB, Goldberg AD, Mead E, Santomasso BD, Landa J, Rimner A, Riviere I, Landgren O, Brentjens RJ. Smith EL, et al. Among authors: landa j. Cancer Immunol Res. 2019 Jul;7(7):1047-1053. doi: 10.1158/2326-6066.CIR-18-0551. Epub 2019 May 21. Cancer Immunol Res. 2019. PMID: 31113804 Free PMC article.
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
Dickson MA, Tap WD, Keohan ML, D'Angelo SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy MM, Ustoyev Y, Crago AM, Singer S, Schwartz GK. Dickson MA, et al. Among authors: landa j. J Clin Oncol. 2013 Jun 1;31(16):2024-8. doi: 10.1200/JCO.2012.46.5476. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569312 Free PMC article. Clinical Trial.
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study.
Autio KA, Klebanoff CA, Schaer D, Kauh JSW, Slovin SF, Adamow M, Blinder VS, Brahmachary M, Carlsen M, Comen E, Danila DC, Doman TN, Durack JC, Fox JJ, Gluskin JS, Hoffman DM, Kang S, Kang P, Landa J, McAndrew PF, Modi S, Morris MJ, Novosiadly R, Rathkopf DE, Sanford R, Chapman SC, Tate CM, Yu D, Wong P, McArthur HL. Autio KA, et al. Among authors: landa j. Clin Cancer Res. 2020 Nov 1;26(21):5609-5620. doi: 10.1158/1078-0432.CCR-20-0855. Epub 2020 Aug 26. Clin Cancer Res. 2020. PMID: 32847933
[Deficiencies].
LANDA JA. LANDA JA. Dia Med. 1954 Feb 22;26(8):202-4. Dia Med. 1954. PMID: 13161649 Undetermined Language. No abstract available.
155 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page